Myron Czuczman - 07 Nov 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Medical Officer
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
07 Nov 2024
Net transactions value
$0
Form type
4
Filing time
12 Nov 2024, 17:00:23 UTC
Previous filing
14 Aug 2024
Next filing
16 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +300,000 $0.000000 300,000 07 Nov 2024 Common Stock 300,000 $0.3800 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 07 Nov 2024 Common Stock 300,000 $0.7000 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 07 Nov 2024 Common Stock 300,000 $1.25 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 07 Nov 2024 Common Stock 300,000 $2.04 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 500,000 07 Nov 2024 Common Stock 500,000 $1.19 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F2 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F3 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F4 The options are fully vested and exercisable immediately.